XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Operating activities:    
Net income $ 98,907 $ 90,208
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 93,652 76,698
Share-based compensation expense 13,366 18,117
Deferred income tax expense 2,213 5,222
Other non-cash expenses 172 364
Changes in operating assets and liabilities:    
Inventories (235,629) (246,457)
Prepaid income taxes and tax receivable (15,008) (14,064)
Prepaid expenses and other assets (12,530) (21,787)
Accounts payable 123,374 79,046
Income taxes payable (19,928) (28,096)
Accrued salaries and wages (6,063) (39,399)
Operating leases 33,841 27,271
Other accrued expenses 15,521 7,895
Net cash provided by (used in) operating activities 91,888 (44,982)
Investing activities:    
Purchases of investment securities and other investments (128,950) (31,815)
Sales, maturities, and redemptions of investment securities 195,795 273,951
Capital expenditures (231,921) (173,589)
Net cash (used in) provided by investing activities (165,076) 68,547
Financing activities:    
Cash paid for Revolving Credit Facility financing costs 0 (248)
Net proceeds from issuance of common stock 440 464
Repurchase and retirement of common stock (80,541) (40,007)
Proceeds from exercise of options to purchase common stock and vesting of restricted and performance-based restricted stock units 288 111
Common shares withheld for taxes (16,395) (4,629)
Net cash used in financing activities (96,208) (44,309)
Net decrease in cash and cash equivalents (169,396) (20,744)
Cash and cash equivalents at beginning of period 332,324 64,973
Cash and cash equivalents at end of period 162,928 44,229
Supplemental disclosures of cash flow information:    
Increase in accrued purchases of property and equipment $ 11,541 $ 6,008